eHealth encompasses the use of information and communication technologies (ICTs) in the support of health and health-related activities. 1 The potential of eHealth to provide innovative solutions to health problems is enormous. This has raised high expectations by the public, by politicians and by healthcare professionals. Many see eHealth solutions as the 'magic bullet' to solve the numerous unsolved problems related to healthcare, particularly in times of constrained healthcare funding. Information and communication technology are expected to reduce the burden of diseases, to improve healthcare delivery and the experience of care for those living with chronic diseases, to facilitate more personalised and person-centred care at the right time and in the right place, and all this at reduced, or at least not increased, cost.
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In contrast, the European Union eHealth action plan for 2012-2020 states that the promise of ICT to increase efficiency, improve quality of life and unlock innovation in health markets remains largely unfulfilled. 2 The main barriers to widespread adoption of eHealth have been identified, and the situation has not significantly improved over the last few years. First of all, the evidence base for the value of eHealth and telemedicine in managing a wide range of cardiovascular disease is increasing but is, on the whole, still weak and contradictory. Second, the development of eHealth and telemedicine is still primarily technically driven and not directed by the needs and expectations of clinically active health professionals. Third, common platforms and connectivity between tools and systems are mostly lacking, there are inherent uncertainties in such systems and there are major issues in the area of privacy and data protection. The use of big data and cloud computing have further magnified this problem. Finally, however, the lack of business cases, cost efficacy calculations and regulation of reimbursement of eHealth and telemedicine have turned out to be the major obstacles to the introduction of evidence-based eHealth and telemedicine tools into the healthcare system.
Recent developments in mobile technology, smartphones, widespread and almost permanent
Internet access, together with the speed of data exchange have accelerated the interest of both patients and industry in further exploring opportunities for using mHealth-related technologies to improve prevention, care and cure. Major companies such as Apple, Google, Samsung, etc. are investing heavily in healthcare-related technologies which will further increase the speed of development.
All these developments are overwhelming and need to be brought into perspective. The position of the European Society of Cardiology (ESC) has been recently described in the European Heart Journal. 3 Cardiovascular medicine is involved with eHealth on many different levels. ESC members deal with the changes in practice that ICT innovation brings, including electronic medical records, e-referrals or e-prescribing, tele-consultation, telemonitoring, mobile health (mHealth) and the use of data mining and machine learning for medical research. Electronic data collection, registries, information networks and semantic inter-operability are further areas of ESC activities. The vision of the ESC is to play a proactive role in all aspects of the eHealth agenda, helping to develop, assess and implement effective ICT innovations in the support of cardiovascular health and health-related activity across Europe.
This supplement is devoted to the third European Congress on eCardiology and eHealth, with the aim of promoting current knowledge in ICT related to cardiovascular disease. The focus is on clinical application, evaluation and integration of eHealth and telemedicine into the healthcare systems of today. However, the integration of eHealth and telemedicine into clinical practice can only be successful if the major stakeholders are communicating better and are working closer together: stakeholders include persons at risk, consumer organisations, patients with cardiovascular disease, patient organisations, heart foundations, healthcare professionals, national professional organisations, health administrations, health insurance organisations, the European Commission, ICT researchers, developers of eHealth solutions, the ICT, pharmaceutical, medical diagnostic, therapeutics and device industries, app developers and mobile device manufacturers.
A clinical update article sets the stage for the range of opportunities and challenges in eHealth and telemedicine. The most promising areas, and also major obstacles, for clinical application are outlined. Topics of particular interest are disease prevention by use of mHealth applications to adhere to a healthy lifestyle, telemedicine care in chronic diseases including arterial hypertension, diabetes and heart failure, and telemonitoring of patients with electronic devices including pacemakers, resynchronisation therapy devices and/or internal defibrillators.
People with unknown atrial fibrillation, often asymptomatic, have a substantially increased risk of stroke. Therefore, screening for atrial fibrillation is a major issue for stroke prevention. The article by Jessica Orchard et al. has been selected for publication in this issue because of the innovative approach to integrate ECG screening into daily routine by primary care nurses during flu vaccination. This feasibility study has great potential to promote widespread use of such easily applicable screening procedures and lead to a reduction in the burden of stroke.
Another innovative approach to integrate eHealth and telemedicine into daily clinical practice, is the use of tele-accelerometry as an alternative to the traditional six-minute walking test for diagnostic and prognostic purposes. This has been evaluated in a field study in Germany and is described in a original research paper in this issue. Results are promising and the application of this test should be further evaluated in larger scale studies.
Although cardiac rehabilitation (CR) is an evidencebased intervention to improve quality of life and to increase survival, it is widely underused. In particular, elderly patients are less frequently referred to CR, show less uptake of CR and more drop-out from CR programmes. Therefore, research efforts are important to improve this situation. The EU-CaRE randomised controlled trial aims at finding solutions to improve CR uptake in elderly patients. In the framework of this European multicentre study, the researchers' plan for finding ways to improve the effectiveness and sustainability of current CR programmes in the elderly is outlined in a study design paper.
This supplement also contains abstracts which have been submitted for this Congress and have been selected by the Congress faculty for publication based on their rating by reviewers. The topics cover a broad spectrum of eHealth and telemedicine and give an insight into the heterogeneity of potential future applications.
We hope that our Congress and this supplement will contribute to close the gap between technically driven progress and clinical application. An important challenge remains to keep the main focus on patient's individual needs and to carefully evaluate the evidence behind the practice.
Declaration of conflicting interests
The author declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
